Novo’s Ozempic Linked to Lower Dementia Rate in Oxford Study - Bloomberg
- Novo’s Ozempic Linked to Lower Dementia Rate in Oxford Study Bloomberg
- Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study FiercePharma
- Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong Study Investor's Business Daily
- Pharmalittle: We're reading about a study of Ozempic and dementia, smaller PBMs, and more STAT
- Ozempic could cut the risk of dementia by half, Oxford study suggests The Telegraph